Meta facebook tracking pixel

Listen Now

Topics Covered

  • Overview of Diffuse Large B-Cell Lymphoma (DLBCL), Including Staging and Grading, In the Context of COVID, Seasonal Flu and RSV
  • Current Standard of Care, New & Emerging Treatment Approaches
  • Treatment Options for Relapsed Refractory DLBCL, Including Bispecific Antibodies
  • Understanding How Bispecific Antibodies Work in the Treatment of Relapsed Refractory DLBCL
  • The Role of Clinical Trials: How Research Contributes to Treatment Options
  • Tips to Prevent & Manage Treatment Side Effects, Symptoms, Discomfort & Pain
  • Talking with Your Health Care Team about Quality-of-Life Concerns
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
  • Questions for Our Panel of Experts

Our Panel of Experts


Catherine S M Diefenbach, MD

Associate Professor of Medicine, Translational Director of Hematology, Director Clinical Lymphoma, Perlmutter Cancer Center, An NCI-designated Comprehensive Cancer Center, NYU Langone Health


Belita Cowan, MA

President, Lymphoma Foundation of America


Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on June 20, 2024.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.